title: Antiangiogenic VEGF-A in peripheral artery disease.
abstract: Vascular endothelial growth factor A (VEGF-A) is a potent proangiogenic cytokine elevated in patients with peripheral artery disease (PAD). A new study links impaired vascular regrowth in PAD to increased expression of an antiangiogenic splice variant of VEGF-A.
authors.affiliation: Department of Biology and the Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Joshua M
authors.initials: JM
authors.lastname: Boucher
authors.affiliation: 1] Department of Biology and the Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. [2] McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Victoria L
authors.initials: VL
authors.lastname: Bautch
mesh_terms: D000818:Animals; D006801:Humans; D018919:Neovascularization, Physiologic / Q000502:physiology*; D058729:Peripheral Arterial Disease / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: D042461:Vascular Endothelial Growth Factor A